Sierra Ocean’s Royalty Pharma RPRX Stock Holding History

Sierra Ocean’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33	Closed	-$1.19K	–	764
2025 Q2	$1.19K	Buy	+33	New	+$1.09K	﹤0.01%	865

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sierra Ocean's RPRX Position: Q3 2025 in Review

Sierra Ocean sold out of Royalty Pharma (RPRX) in Q3 2025, closing a stake of 33 shares — an estimated $1.19K sold.

Sierra Ocean first reported a position in RPRX in Q2 2025 and held it in 1 quarter. The position peaked at $1.19K in Q2 2025. 487 funds tracked by Wall St. Rank hold RPRX as of Q3 2025.

Sierra Ocean reported no remaining Royalty Pharma position as of Q3 2025 after selling out during the quarter.
Sierra Ocean sold 33 Royalty Pharma shares in Q3 2025, an estimated $1.19K.
Sierra Ocean first reported a position in Royalty Pharma in Q2 2025 and held it in 1 quarter.
Sierra Ocean's Royalty Pharma position peaked at $1.19K in Q2 2025.
487 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.